You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 

You are reading 1 of 2 free-access articles allowed for 30 days

HSE Medicines Management Programme launches two new preferred drugs

By Mindo - 20th Sep 2016 | 1 views

The MMP was established in 2013 under the leadership of Prof Michael Barry with the aim of promoting safe, effective and cost-effective prescribing among GPs. The MMP has undertaken a number of initiatives aimed at enhancing evidence-based and cost-effective prescribing nationally.

One of these is the preferred drugs initiative, which identifies a single ‘preferred drug’ within a therapeutic drug class, and offers prescribers useful guidance on selecting, prescribing and monitoring this drug for a particular condition.

Prescribers are encouraged to make the preferred drug their drug of first choice when prescribing from that therapeutic class.

In total, there are now ten preferred drugs selected by the MMP. These drug groups account for 25 per cent of total prescribing on the GMS scheme. Total expenditure on these ten therapeutic areas was €253 million in 2014.

“If we choose better value medicines, we can make savings to fund other areas of the health service,” commented Prof Barry. “For example, if we prescribe any other statin in preference to rosuvastatin and, if we choose any other PPI in preference to esomeprazole (or rabeprazole), savings of over €5.7 million per year can be achieved. At a time of increasing demand on our health service we need to make the right choices.”

For further information, visit http://www.hse.ie/eng/about/Who/clinical/natclinprog/medicinemanagementprogramme/

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read